Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Future

Battling breast cancer with precision medicine (Part 1)

Laura Holmes Haddad is a breast cancer survivor. She made the incredibly brave decision to participate in a PARP inhibitor precision medicine trial. Here, the author and precision medicine advocate...

Blue Latitude Health

The role of brain health in treating MS

Blue Latitude Health speaks to Professor Gavin Giovannoni, key opinion leader and Chair of Neurology, Barts and The London School of Medicine and Dentistry, about his theories on brain health,...

Blue Latitude Health

- PMLiVE

A postcard from Cannes

This week sees the annual Cannes Lions International Festival of Creativity, bringing together leading creative talent from across the globe to learn, share and inspire each other. Until recently, pharmaceuticals...

Bedrock Healthcare Communications

- PMLiVE

Sanofi taps Google’s expertise for digital transformation

Pharma giant embraces AI with new partnership

Secrets of Pharma Advertising

If the goal of branding is to be different, why do so many Pharma brand ads look the same?

Life Healthcare Communications

- PMLiVE

A variety of backgrounds, a unified purpose

How did Bedrock become Bedrock? We asked members of the Bedrock team how they found their way into the (somewhat hidden) world of medical communications, and what they love about...

Bedrock Healthcare Communications

- PMLiVE

Wanda Lesowiec did it. Could you?

How a background in pharma can mean a bright future in medical communications

Bedrock Healthcare Communications

- PMLiVE

Am I wrong to be apprehensive about gene therapy?

Is the introduction of gene therapy going to be smooth sailing? Origin's Strategic Solutions Director, Su Smith, shares her thoughts.

Bedrock Healthcare Communications

- PMLiVE

Bedrock Group announces the launch of Origins, a health experience research company

Bedrock Group is proud to announce the launch of Origins, a health experience research company.

Bedrock Healthcare Communications

- PMLiVE

Myovant’s fibroids drug clears phase 3 trial, but shares sink

Investors concerned on how it stacks up against AbbVie rival

- PMLiVE

Data regulations impeding AI use in drug research

Lack of data specialists another concern

- PMLiVE

Snowflake advertising in a burnt-out world

How do you appeal to people who are too tired to care?

Life Healthcare Communications

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links